Search research articles
Contact Us
Filters
Showing results (121-130 of 269) with videos related to
Page
of 27
Sort By:
Antioxidants (Basel, Switzerland)
|
January 30, 2020
Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension
Mathews Valuparampil Varghese, Maki Niihori, Cody A Eccles, et al.
The Journal of Biological Chemistry
|
August 30, 2011
Ca2+ influx through reverse mode Na+/Ca2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells
Petros Andrikopoulos, Akemichi Baba, Toshio Matsuda, et al.
International Journal of Cancer
|
October 2, 2003
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients
Matthew G Tutton, Mark L George, Suzanne A Eccles, et al.
BMC Cancer
|
May 24, 2022
HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
Kamolporn Amornsupak, Suyanee Thongchot, Chanida Thinyakul, et al.
Atherosclerosis
|
May 20, 2008
Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow
Kirstie A Eccles, Heather Sowden, Karen E Porter, et al.
Cancer Research
|
June 15, 1996
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
S A Eccles, G M Box, W J Court, et al.
Cancer Research
|
March 8, 2000
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells
P O-charoenrat, H Modjtahedi, P Rhys-Evans, et al.
Oncotarget
|
January 19, 2017
The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair
Petar Jelinic, Laura A Eccles, Jill Tseng, et al.
Cell Biophysics
|
January 1, 1993
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
C J Dean, S A Eccles, M Valeri, et al.
Cancer Research
|
October 1, 1994
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185
S A Eccles, W J Court, G A Box, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 269) with videos related to
Sort By:
Page
of 27
Antioxidants (Basel, Switzerland)
|
January 30, 2020
Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension
Mathews Valuparampil Varghese, Maki Niihori, Cody A Eccles, et al.
The Journal of Biological Chemistry
|
August 30, 2011
Ca2+ influx through reverse mode Na+/Ca2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells
Petros Andrikopoulos, Akemichi Baba, Toshio Matsuda, et al.
International Journal of Cancer
|
October 2, 2003
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients
Matthew G Tutton, Mark L George, Suzanne A Eccles, et al.
BMC Cancer
|
May 24, 2022
HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
Kamolporn Amornsupak, Suyanee Thongchot, Chanida Thinyakul, et al.
Atherosclerosis
|
May 20, 2008
Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow
Kirstie A Eccles, Heather Sowden, Karen E Porter, et al.
Cancer Research
|
June 15, 1996
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
S A Eccles, G M Box, W J Court, et al.
Cancer Research
|
March 8, 2000
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells
P O-charoenrat, H Modjtahedi, P Rhys-Evans, et al.
Oncotarget
|
January 19, 2017
The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair
Petar Jelinic, Laura A Eccles, Jill Tseng, et al.
Cell Biophysics
|
January 1, 1993
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
C J Dean, S A Eccles, M Valeri, et al.
Cancer Research
|
October 1, 1994
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185
S A Eccles, W J Court, G A Box, et al.
Page
of 27